| Product Code: ETC7745175 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Pediatric Vaccines Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Pediatric Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Pediatric Vaccines Market - Industry Life Cycle |
3.4 Japan Pediatric Vaccines Market - Porter's Five Forces |
3.5 Japan Pediatric Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Pediatric Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Japan Pediatric Vaccines Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Japan Pediatric Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of pediatric vaccination in Japan |
4.2.2 Government initiatives to promote pediatric vaccination coverage |
4.2.3 Growing prevalence of infectious diseases among children in Japan |
4.3 Market Restraints |
4.3.1 High cost associated with pediatric vaccines |
4.3.2 Stringent regulatory requirements for vaccine approval in Japan |
4.3.3 Limited availability of pediatric vaccine options in the market |
5 Japan Pediatric Vaccines Market Trends |
6 Japan Pediatric Vaccines Market, By Types |
6.1 Japan Pediatric Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Pediatric Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan Pediatric Vaccines Market Revenues & Volume, By Monovalent, 2021- 2031F |
6.1.4 Japan Pediatric Vaccines Market Revenues & Volume, By Multivalent, 2021- 2031F |
6.2 Japan Pediatric Vaccines Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Japan Pediatric Vaccines Market Revenues & Volume, By Live Attenuated Vaccines, 2021- 2031F |
6.2.3 Japan Pediatric Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.2.4 Japan Pediatric Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.2.5 Japan Pediatric Vaccines Market Revenues & Volume, By Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines, 2021- 2031F |
6.3 Japan Pediatric Vaccines Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Japan Pediatric Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3.3 Japan Pediatric Vaccines Market Revenues & Volume, By Human Papilloma Virus, 2021- 2031F |
6.3.4 Japan Pediatric Vaccines Market Revenues & Volume, By Measles, Mumps and Rubella, 2021- 2031F |
6.3.5 Japan Pediatric Vaccines Market Revenues & Volume, By Meningococcal Disease, 2021- 2031F |
6.3.6 Japan Pediatric Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.3.7 Japan Pediatric Vaccines Market Revenues & Volume, By Polio, 2021- 2031F |
6.3.8 Japan Pediatric Vaccines Market Revenues & Volume, By Diphtheria, Pertussis and Tetanus, 2021- 2031F |
6.3.9 Japan Pediatric Vaccines Market Revenues & Volume, By Diphtheria, Pertussis and Tetanus, 2021- 2031F |
7 Japan Pediatric Vaccines Market Import-Export Trade Statistics |
7.1 Japan Pediatric Vaccines Market Export to Major Countries |
7.2 Japan Pediatric Vaccines Market Imports from Major Countries |
8 Japan Pediatric Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rate among children in Japan |
8.2 Number of pediatric vaccine doses administered annually |
8.3 Rate of adverse reactions reported for pediatric vaccines in Japan |
9 Japan Pediatric Vaccines Market - Opportunity Assessment |
9.1 Japan Pediatric Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Pediatric Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Japan Pediatric Vaccines Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Japan Pediatric Vaccines Market - Competitive Landscape |
10.1 Japan Pediatric Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Japan Pediatric Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here